Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Mancuso, M. R.
Chapter 1. Cancer Biology, Signaling Pathways, and Malignant Transformation Hallmarks Of Cancer
Mapatumumab Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Targeting Apoptosis
MAPK Application Of The Hallmarks Of Cancer Bone Metastasis Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Glossary Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Hypoxia-Inducible Factor, Mtor, and Angiogenesis Insulin-Like Growth Factor Receptor Pathway Targets Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Mitotic Kinase Inhibitors Protein Kinase Signaling Pathways References (Chapter 2) References (Chapter 3)
MAPK pathway Insulin-Like Growth Factor Receptor Pathway Targets Invasion and Metastasis Protein Kinase Signaling Pathways References (Chapter 2)
Matrix metalloproteinases Glossary Invasion and Metastasis Targeting Angiogenesis
MDSS,
Medicare, therapy and reimbursement requirements through
MedWatch
Meibomian glands
Meibomitis
MEK Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Protein Kinase Signaling Pathways Targeting Angiogenesis
MEK1
MEK2
Membrane-bound receptor kinases Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets EGFR pathway Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies monoclonal antibodies targeted against EGFR NCI-CTCAE criteria for diarrhea skin rash, and disturbances of skin appendages, with risk for infection, 80-90 diarrhea as class effect of EGFRIs, 89-90 eyelid changes, 88 minimizing skin rash-plan for, 82-88 nursing assessment/management, 82 tear film changes targeting the EGFR pathway-EGFR and its inhibitors
Membrane type 1 Invasion and Metastasis matrix metalloproteinase Targeting Angiogenesis
Mesoderm Glossary Invasion and Metastasis
Mesynchymal-epithelial transition Application Of The Hallmarks Of Cancer Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Mesynchymal-epithelial transition factor Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
MET,
Metalloproteinase inhibitors
Metaprolol, gefitinib coadministered with
Metastasis invasion and learning more about overexpression of HER family receptors and
Metastasis,
Methylation, comparison of
Methylation in DNA, modification of
mFOLFOX6 Nursing Considerations and Drug Information References (Chapter 3)
Microarray in Node-Negative Disease May Avoid Chemotherapy trial
Microenvironment
Micrometastasis, movement to macrometastasis